Caribou Biosciences Debt-to-Equity Ratio Growth & History (CRBU)
Caribou Biosciences's debt-to-equity ratio was 0.22 for fiscal 2025.
View full Caribou Biosciences company overviewCaribou Biosciences annual debt-to-equity ratio history
| Fiscal year | Period ended | Debt-to-equity ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.22 | 0.12 | +112.82% |
| 2024 | 2024-12-31 | 0.10 | 0.03 | +42.30% |
| 2023 | 2023-12-31 | 0.07 | −0.02 | −20.21% |
| 2022 | 2022-12-31 | 0.09 | 0.09 | — |
| 2021 | 2021-12-31 | 0.00 | — | — |
Caribou Biosciences quarterly debt-to-equity ratio
| Fiscal quarter | Period ended | Debt-to-equity ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.27 | 0.12 | +74.61% |
| Q1 2026 | 2026-03-31 | 0.26 | 0.14 | +118.79% |
| Q4 2025 | 2025-12-31 | 0.22 | 0.12 | +112.82% |
| Q3 2025 | 2025-09-30 | 0.18 | 0.08 | +89.49% |
| Q2 2025 | 2025-06-30 | 0.16 | 0.07 | +80.33% |
| Q1 2025 | 2025-03-31 | 0.12 | 0.04 | +52.60% |
| Q4 2024 | 2024-12-31 | 0.10 | 0.03 | +42.30% |
| Q3 2024 | 2024-09-30 | 0.09 | 0.03 | +37.43% |
| Q2 2024 | 2024-06-30 | 0.09 | −0.01 | −14.62% |
| Q1 2024 | 2024-03-31 | 0.08 | −0.02 | −19.72% |
| Q4 2023 | 2023-12-31 | 0.07 | −0.02 | −20.21% |
| Q3 2023 | 2023-09-30 | 0.07 | −0.02 | −19.83% |
| Q2 2023 | 2023-06-30 | 0.10 | 0.02 | +25.72% |
| Q1 2023 | 2023-03-31 | 0.10 | 0.02 | +30.56% |
| Q4 2022 | 2022-12-31 | 0.09 | 0.09 | — |
| Q3 2022 | 2022-09-30 | 0.09 | — | — |
| Q2 2022 | 2022-06-30 | 0.08 | — | — |
| Q1 2022 | 2022-03-31 | 0.08 | — | — |
| Q4 2021 | 2021-12-31 | 0.00 | — | — |
Caribou Biosciences debt-to-equity ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Caribou Biosciences's debt-to-equity ratio increased from 0.00 to 0.22, a change of 0.22. The latest reported quarter, Q2 2026, shows 0.27.
What the debt-to-equity ratio means
The debt-to-equity ratio compares interest-bearing debt with shareholders’ equity. It helps show how much debt financing a company uses relative to its accounting equity, but useful comparison levels vary by industry.
How debt-to-equity is calculated
TickerStat calculates debt-to-equity as total interest-bearing debt divided by SEC-reported shareholders’ equity for the same balance-sheet date. Total liabilities are not treated as debt, and periods with non-positive equity are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Caribou Biosciences source filings ↗